ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
dr reddy's irbesartan irbesartan 150 mg film coated tablet bottle
dr reddys laboratories australia pty ltd - irbesartan -
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
dr reddy's irbesartan irbesartan 150 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - irbesartan -
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
dr reddy's irbesartan irbesartan 75 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - irbesartan -
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
dr reddy's irbesartan irbesartan 300 mg film coated tablet bottle
dr reddys laboratories australia pty ltd - irbesartan -
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
dr reddy's irbesartan irbesartan 75 mg film coated tablet bottle
dr reddys laboratories australia pty ltd - irbesartan -
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
budenofalk budesonide foam 2 mg cans
dr falk pharma australia pty ltd - budesonide, quantity: 2 mg - foam - excipient ingredients: propylene glycol; purified water; emulsifying wax; cetyl alcohol; citric acid monohydrate; disodium edetate; butane; isobutane; propane; steareth-10 - budenofalk foam is indicated in the treatment of active rectal and rectosigmoid disease in ulcerative colitis.
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
salofalk foam mesalazine 1g/application aerosol can
dr falk pharma australia pty ltd - mesalazine, quantity: 1 g - foam - excipient ingredients: propane; cetostearyl alcohol; disodium edetate; propylene glycol; butane; polysorbate 60; isobutane; sodium metabisulfite - salofalk foam enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
salofalk enemas mesalazine 2g/60ml enema bottle
dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
salofalk enemas mesalazine 4g/60ml enema bottle
dr falk pharma australia pty ltd - mesalazine, quantity: 4000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.
ऑस्ट्रेलिया -
अंग्रेज़ी -
Department of Health (Therapeutic Goods Administration)
salofalk enemas mesalazine 2g/30ml enema bottle
dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: disodium edetate; potassium acetate; purified water; xanthan gum; potassium metabisulfite; carbomer 934p; sodium benzoate - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.